B+
Bull case
20%
Probability
Target price
$9.38
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
MGTX
MeiraGTxFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Bull case assumes positive clinical readouts and at least one partnering/licensing deal within three months that materially de-risks programs and accelerates milestones, prompting re-rating versus peers.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Clinical trial failure or safety signal
Momentum
81
Value
64
Sentiment
3
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.33 · Bull $9.38 · Bear $3.52Analysis 2025-10-10; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-10 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $29.43
Why
Momentum81 · Δ7d +0.5
Value64 · Δ7d 0.0
Sentiment3 · Δ7d +2.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Clinical trial failure or safety signal
- • Faster-than-expected cash burn requiring dilutive financing
- • Bear case assumes negative or delayed readouts, higher-than-expected cash burn leading to dilution, and no partnership, compressing valuation and liquidity for further R&D.
Catalyst clock
No dated catalyst is available.
Clinical trial readouts for lead gene-therapy programs
Lead driver: Value · See fundamentals
Momentum
81
9% active weight
Current posture
7d trendImproving
Δ7d
+0.5
Δ21d
-3.8
Value
64
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+15.4
Sentiment
3
62% active weight
Current posture
7d trendImproving
Δ7d
+2.0
Δ21d
+2.0
Why this grade
Composite grade F. Momentum 81.3 / Value 63.9 / Sentiment 3.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-10-10. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$7.33
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$3.52
Analysis reference price unavailable
Analysis 2025-10-10 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.32B
Beta
1.38
Shares Out
96.04M
P/E (TTM) · Derived
-9.7
P/S (TTM)
22.17
P/FCF (TTM) · Derived
71.31
Rev YoY
+8608.6%
EPS YoY
-455.9%
Gross Margin
+94.9%
Op Margin
+45.9%
Net Debt
$22.76M
Current Ratio
3.76
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data